Laddar...
Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder
Personalizing treatment for late-life depression requires identifying and integrating information from multiple factors that influence treatment efficacy (moderators). We performed exploratory moderator analyses using data from a multi-site, randomized, placebo-controlled, double-blind trial of arip...
Sparad:
| I publikationen: | J Psychiatr Res |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5021594/ https://ncbi.nlm.nih.gov/pubmed/27438687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2016.07.005 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|